HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36 | 0.0% | 31,185 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $36 | -83.9% | 31,185 | -78.9% | 0.02% | -81.8% |
| Q1 2023 | $223 | -39.7% | 147,862 | 0.0% | 0.13% | -37.4% |
| Q4 2022 | $370 | -99.8% | 147,862 | +179.7% | 0.21% | +48.6% |
| Q3 2022 | $223,000 | +51.7% | 52,862 | 0.0% | 0.14% | +61.4% |
| Q2 2022 | $147,000 | -51.8% | 52,862 | -0.9% | 0.09% | -44.7% |
| Q1 2022 | $305,000 | -37.4% | 53,362 | 0.0% | 0.16% | -35.1% |
| Q4 2021 | $487,000 | -14.4% | 53,362 | +0.2% | 0.24% | -16.7% |
| Q3 2021 | $569,000 | -36.0% | 53,262 | -7.0% | 0.29% | -30.3% |
| Q2 2021 | $889,000 | +247.3% | 57,261 | +262.4% | 0.42% | +257.6% |
| Q1 2021 | $256,000 | +6.2% | 15,799 | +38.6% | 0.12% | -9.2% |
| Q4 2020 | $241,000 | +62.8% | 11,400 | +14.0% | 0.13% | +21.5% |
| Q3 2020 | $148,000 | +0.7% | 10,000 | 0.0% | 0.11% | +2.9% |
| Q2 2020 | $147,000 | +25.6% | 10,000 | 0.0% | 0.10% | -11.1% |
| Q1 2020 | $117,000 | – | 10,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |